- Field Trip Health Ltd. (FTRP) has agreed to increase the size of its C$50M bought deal offering of common shares
- The underwriters have agreed to purchase 12,750,000 common shares at a price of C$6.50 per share for gross proceeds of C$82,875,000
- Field Trip has granted the Underwriters an over-allotment option
- If the over-allotment option is fully exercised, the aggregate gross proceeds of the offering will be C$95,306,250
- Field Trip is the global leader in the development and delivery of psychedelic therapies
- Field Trip Health Ltd. (FTRP) is trading flat at C$8.00 per share at 10:45 am EST
Field Trip Health Ltd. (FTRP) has agreed to increase the size of its C$50M bought deal offering of common shares.
The underwriters have agreed to purchase 12,750,000 common shares at a price of C$6.50 per share for aggregate gross proceeds of $82,875,000.
Field Trip intends to use the proceeds from the offering for the ongoing development of the “FT-104” novel psychedelic development program, the opening of new Field Trip Health centers, and for working capital and general corporate purposes.
Field Trip has granted the Underwriters an over-allotment option exercisable any time on or up to 30 days after the March 16 closing date to purchase up to an additional number of common shares equal to 15% of the number of shares sold during the offering.
If the over-allotment option is fully exercised, the aggregate gross proceeds of the offering will be C$95,306,250.
The offering is scheduled to close on or about March 16, 2021 and is subject to the approval of the Canadian Securities Exchange and the securities regulatory authorities.
Field Trip is the global leader in the development and delivery of psychedelic therapies.
Field Trip Health Ltd. (FTRP) is trading flat at C$8.00 per share at 10:45 am EST.
